Switch to:
Also traded in: Germany, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.08
SNN's Cash to Debt is ranked lower than
95% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SNN: 0.08 )
Ranked among companies with meaningful Cash to Debt only.
SNN' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.35 Max: No Debt
Current: 0.08
Equity to Asset 0.56
SNN's Equity to Asset is ranked lower than
63% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SNN: 0.56 )
Ranked among companies with meaningful Equity to Asset only.
SNN' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.52 Max: 0.74
Current: 0.56
0.26
0.74
Interest Coverage 17.77
SNN's Interest Coverage is ranked lower than
75% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. SNN: 17.77 )
Ranked among companies with meaningful Interest Coverage only.
SNN' s Interest Coverage Range Over the Past 10 Years
Min: 8.87  Med: 37.28 Max: 94
Current: 17.77
8.87
94
F-Score: 6
Z-Score: 5.13
M-Score: -2.78
WACC vs ROIC
6.78%
12.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.59
SNN's Operating margin (%) is ranked higher than
84% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. SNN: 16.59 )
Ranked among companies with meaningful Operating margin (%) only.
SNN' s Operating margin (%) Range Over the Past 10 Years
Min: 14.63  Med: 18.90 Max: 23.22
Current: 16.59
14.63
23.22
Net-margin (%) 11.18
SNN's Net-margin (%) is ranked higher than
79% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SNN: 11.18 )
Ranked among companies with meaningful Net-margin (%) only.
SNN' s Net-margin (%) Range Over the Past 10 Years
Min: 9.38  Med: 12.92 Max: 26.81
Current: 11.18
9.38
26.81
ROE (%) 15.95
SNN's ROE (%) is ranked higher than
77% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. SNN: 15.95 )
Ranked among companies with meaningful ROE (%) only.
SNN' s ROE (%) Range Over the Past 10 Years
Min: 12.67  Med: 21.73 Max: 39.32
Current: 15.95
12.67
39.32
ROA (%) 8.71
SNN's ROA (%) is ranked higher than
79% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. SNN: 8.71 )
Ranked among companies with meaningful ROA (%) only.
SNN' s ROA (%) Range Over the Past 10 Years
Min: 7.79  Med: 10.91 Max: 22.64
Current: 8.71
7.79
22.64
ROC (Joel Greenblatt) (%) 45.41
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. SNN: 45.41 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SNN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 34.88  Med: 43.85 Max: 56.33
Current: 45.41
34.88
56.33
Revenue Growth (3Y)(%) 2.50
SNN's Revenue Growth (3Y)(%) is ranked lower than
55% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SNN: 2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SNN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 1  Med: 8.90 Max: 37.2
Current: 2.5
1
37.2
EBITDA Growth (3Y)(%) 0.80
SNN's EBITDA Growth (3Y)(%) is ranked lower than
54% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. SNN: 0.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SNN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.4  Med: 13.95 Max: 36.3
Current: 0.8
-2.4
36.3
EPS Growth (3Y)(%) -4.50
SNN's EPS Growth (3Y)(%) is ranked lower than
60% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SNN: -4.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SNN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -5.3  Med: 14.85 Max: 57
Current: -4.5
-5.3
57
» SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

SNN Guru Trades in Q1 2015

Eric Mindich 502,000 sh (New)
Ken Fisher 2,299,852 sh (+0.35%)
Pioneer Investments 84,570 sh (unchged)
Jim Simons 310,000 sh (-9.84%)
Mario Gabelli 25,875 sh (-18.82%)
David Dreman 117,479 sh (-21.04%)
John Hussman 15,000 sh (-69.23%)
» More
Q2 2015

SNN Guru Trades in Q2 2015

Steven Cohen 50,600 sh (New)
John Hussman 15,000 sh (unchged)
Eric Mindich 502,000 sh (unchged)
Pioneer Investments 84,570 sh (unchged)
Ken Fisher 2,083,106 sh (-9.42%)
David Dreman 103,704 sh (-11.73%)
Jim Simons 144,250 sh (-53.47%)
Mario Gabelli 6,375 sh (-75.36%)
» More
Q3 2015

SNN Guru Trades in Q3 2015

Jim Simons 195,250 sh (+35.36%)
Eric Mindich 567,193 sh (+12.99%)
Mario Gabelli 6,975 sh (+9.41%)
Ken Fisher 2,190,240 sh (+5.14%)
Pioneer Investments 84,690 sh (+0.14%)
John Hussman 15,000 sh (unchged)
David Dreman Sold Out
Steven Cohen 23,000 sh (-54.55%)
» More
Q4 2015

SNN Guru Trades in Q4 2015

Ken Fisher 2,207,255 sh (+0.78%)
Pioneer Investments Sold Out
John Hussman Sold Out
Mario Gabelli 6,775 sh (-2.87%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 26.73
SNN's P/E(ttm) is ranked higher than
50% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 27.86 vs. SNN: 26.73 )
Ranked among companies with meaningful P/E(ttm) only.
SNN' s P/E(ttm) Range Over the Past 10 Years
Min: 10.23  Med: 19.84 Max: 41.04
Current: 26.73
10.23
41.04
Forward P/E 17.09
SNN's Forward P/E is ranked higher than
96% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 18.66 vs. SNN: 17.09 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.63
SNN's PE(NRI) is ranked higher than
51% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 28.10 vs. SNN: 26.63 )
Ranked among companies with meaningful PE(NRI) only.
SNN' s PE(NRI) Range Over the Past 10 Years
Min: 11.57  Med: 23.27 Max: 41.76
Current: 26.63
11.57
41.76
P/B 3.55
SNN's P/B is ranked lower than
71% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 2.63 vs. SNN: 3.55 )
Ranked among companies with meaningful P/B only.
SNN' s P/B Range Over the Past 10 Years
Min: 2.33  Med: 3.87 Max: 7.15
Current: 3.55
2.33
7.15
P/S 2.93
SNN's P/S is ranked higher than
73% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. SNN: 2.93 )
Ranked among companies with meaningful P/S only.
SNN' s P/S Range Over the Past 10 Years
Min: 1.67  Med: 2.80 Max: 4.08
Current: 2.93
1.67
4.08
PFCF 25.62
SNN's PFCF is ranked higher than
61% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 32.78 vs. SNN: 25.62 )
Ranked among companies with meaningful PFCF only.
SNN' s PFCF Range Over the Past 10 Years
Min: 12.58  Med: 27.94 Max: 190.33
Current: 25.62
12.58
190.33
POCF 15.67
SNN's POCF is ranked higher than
68% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 19.65 vs. SNN: 15.67 )
Ranked among companies with meaningful POCF only.
SNN' s POCF Range Over the Past 10 Years
Min: 8.23  Med: 16.36 Max: 38.07
Current: 15.67
8.23
38.07
EV-to-EBIT 20.81
SNN's EV-to-EBIT is ranked higher than
59% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 24.07 vs. SNN: 20.81 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.5  Med: 15.80 Max: 29.8
Current: 20.81
7.5
29.8
EV-to-EBITDA 13.37
SNN's EV-to-EBITDA is ranked higher than
66% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 17.52 vs. SNN: 13.37 )
Ranked among companies with meaningful EV-to-EBITDA only.
SNN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.8  Med: 11.20 Max: 21.2
Current: 13.37
5.8
21.2
PEG 10.96
SNN's PEG is ranked lower than
79% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 3.39 vs. SNN: 10.96 )
Ranked among companies with meaningful PEG only.
SNN' s PEG Range Over the Past 10 Years
Min: 0.35  Med: 0.79 Max: 18.4
Current: 10.96
0.35
18.4
Shiller P/E 26.73
SNN's Shiller P/E is ranked higher than
59% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 32.91 vs. SNN: 26.73 )
Ranked among companies with meaningful Shiller P/E only.
SNN' s Shiller P/E Range Over the Past 10 Years
Min: 18.08  Med: 23.35 Max: 32.35
Current: 26.73
18.08
32.35
Current Ratio 1.99
SNN's Current Ratio is ranked lower than
61% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. SNN: 1.99 )
Ranked among companies with meaningful Current Ratio only.
SNN' s Current Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.91 Max: 2.75
Current: 1.99
0.8
2.75
Quick Ratio 1.02
SNN's Quick Ratio is ranked lower than
77% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SNN: 1.02 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s Quick Ratio Range Over the Past 10 Years
Min: 0.45  Med: 1.09 Max: 1.62
Current: 1.02
0.45
1.62
Days Inventory 301.39
SNN's Days Inventory is ranked lower than
89% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. SNN: 301.39 )
Ranked among companies with meaningful Days Inventory only.
SNN' s Days Inventory Range Over the Past 10 Years
Min: 253.48  Med: 300.55 Max: 336.55
Current: 301.39
253.48
336.55
Days Sales Outstanding 76.24
SNN's Days Sales Outstanding is ranked lower than
55% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. SNN: 76.24 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.53  Med: 82.44 Max: 94.34
Current: 76.24
76.53
94.34

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.99
SNN's Dividend Yield is ranked higher than
62% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. SNN: 1.99 )
Ranked among companies with meaningful Dividend Yield only.
SNN' s Dividend Yield Range Over the Past 10 Years
Min: 0.84  Med: 1.46 Max: 2.28
Current: 1.99
0.84
2.28
Dividend Payout 0.73
SNN's Dividend Payout is ranked higher than
62% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. SNN: 0.73 )
Ranked among companies with meaningful Dividend Payout only.
SNN' s Dividend Payout Range Over the Past 10 Years
Min: 0.28  Med: 0.61 Max: 11.67
Current: 0.73
0.28
11.67
Dividend Growth (3y) 14.40
SNN's Dividend Growth (3y) is ranked higher than
73% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SNN: 14.40 )
Ranked among companies with meaningful Dividend Growth (3y) only.
SNN' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -54  Med: 9.65 Max: 19.6
Current: 14.4
-54
19.6
Forward Dividend Yield 2.41
SNN's Forward Dividend Yield is ranked higher than
91% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. SNN: 2.41 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 4.24
SNN's Yield on cost (5-Year) is ranked higher than
84% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SNN: 4.24 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SNN' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.81  Med: 3.32 Max: 4.52
Current: 4.24
1.81
4.52
3-Year Average Share Buyback Ratio 0.10
SNN's 3-Year Average Share Buyback Ratio is ranked higher than
82% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. SNN: 0.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SNN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.4  Med: 1.00 Max: 23.3
Current: 0.1
-0.4
23.3

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 31.79
SNN's Price/Tangible Book is ranked lower than
95% of the 362 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. SNN: 31.79 )
Ranked among companies with meaningful Price/Tangible Book only.
SNN' s Price/Tangible Book Range Over the Past 10 Years
Min: 4.14  Med: 11.65 Max: 166.75
Current: 31.79
4.14
166.75
Price/Projected FCF 2.01
SNN's Price/Projected FCF is ranked lower than
52% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. SNN: 2.01 )
Ranked among companies with meaningful Price/Projected FCF only.
SNN' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.07  Med: 1.94 Max: 5.1
Current: 2.01
1.07
5.1
Price/DCF (Earnings Based) 1.35
SNN's Price/DCF (Earnings Based) is ranked higher than
66% of the 35 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. SNN: 1.35 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 2.30
SNN's Price/Median PS Value is ranked lower than
94% of the 374 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. SNN: 2.30 )
Ranked among companies with meaningful Price/Median PS Value only.
SNN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.55  Med: 1.21 Max: 2.52
Current: 2.3
0.55
2.52
Price/Graham Number 6.51
SNN's Price/Graham Number is ranked lower than
84% of the 248 Companies
in the Global Medical Devices industry.

( Industry Median: 2.73 vs. SNN: 6.51 )
Ranked among companies with meaningful Price/Graham Number only.
SNN' s Price/Graham Number Range Over the Past 10 Years
Min: 1.55  Med: 3.62 Max: 17.1
Current: 6.51
1.55
17.1
Earnings Yield (Greenblatt) (%) 4.83
SNN's Earnings Yield (Greenblatt) (%) is ranked higher than
74% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. SNN: 4.83 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SNN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 3.4  Med: 6.30 Max: 13.3
Current: 4.83
3.4
13.3
Forward Rate of Return (Yacktman) (%) 3.94
SNN's Forward Rate of Return (Yacktman) (%) is ranked higher than
51% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. SNN: 3.94 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SNN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -1.5  Med: 22.90 Max: 68.5
Current: 3.94
-1.5
68.5

More Statistics

Revenue(Mil) $4617
EPS $ 1.11
Beta0.83
Short Percentage of Float0.13%
52-Week Range $30.23 - 37.84
Shares Outstanding(Mil)475.51

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 4,910 5,153 5,449
EPS($) 1.87 1.84 2.08
EPS without NRI($) 1.87 1.84 2.08

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:NPWA.Germany, SN..UK, SNNUF.USA,
Smith & Nephew PLC was incorporated on February 17, 1937. The Company develops, manufactures, markets and sells medical devices. The Company is organized into business segments namely Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices offers Orthopaedic Reconstruction which includes Hip Implants, Knee Implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery, Trauma & Extremities consisting of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures, Sports Medicine Joint Repair, which offers surgeons a various instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, Arthroscopy Enabling Technologies which offer healthcare providers various technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualisation inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. The Advanced Wound Management segment offers Advanced Wound Care includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds, Advanced Wound Devices consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems, Advanced Wound Bioactives includes biologics and other bioactive technologies that provide approaches to debridement and dermal repair/regeneration. The Company operates across the world and is subject to legislation, including anti-bribery and corruption and data protection, in each country in which it operates.
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Invesco European Growth Fund Adds to 7 Stakes Jan 26 2016 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 

More From Other Websites
UBS Downgrades Smith & Nephew, Says Margin Upside 'Elusive' Feb 11 2016
Smith & Nephew Plc Earnings Analysis: 2015 By the Numbers Feb 08 2016
Why I’d Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
[$$] Smith & Nephew says results prove it can rival big groups Feb 04 2016
Smith & Nephew eyes acquisitions as sales slip Feb 04 2016
Smith & Nephew eyes acquisitions Feb 04 2016
Today’s Results Suggest Smith & Nephew plc Looks Set To Beat Vodafone plc Feb 04 2016
Today's Results Suggest Smith & Nephew plc Looks Set To Beat Vodafone plc Feb 04 2016
Smith & Nephew sees revenues up, but forex to hit margins Feb 04 2016
Smith & Nephew sees revenues up, but forex to hit margins Feb 04 2016
Smith & Nephew 2015 trading profit beats expectations Feb 04 2016
BUZZ-Smith & Nephew drops as Stryker buys Sage Products Feb 01 2016
[$$] Smith & Nephew chief executive has 'highly treatable' cancer Feb 01 2016
Smith & Nephew boss reveals cancer diagnosis Feb 01 2016
Smith & Nephew CEO Bohuon diagnosed with cancer Feb 01 2016
Smith & Nephew CEO Bohuon diagnosed with cancer Feb 01 2016
Statement regarding Olivier Bohuon Feb 01 2016
Smith & Nephew Chief Executive Bohuon Diagnosed With Cancer Feb 01 2016
GlaxoSmithKline plc And Smith & Nephew plc: Healthy Stock Stars For Your Portfolio! Jan 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK